The peptide stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat formation) in adipose tissue
doi: 10.1016/S0140-6736(19)32517-6 Summary Keywords non-alcoholic steatohepatitis, nonalcoholic fatty liver disease, obesity, insulin resistance, metabolic syndrome, metabolic disease, fibroblast growth factor 21 Citation Tillman EJ and Rolph T (2020) FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases
Pseudomonas aeruginosa utilizes 15-lipoxygenase released in vesicles to oxidize host arachidonic acid phosphatidylethanolamine into ferroptotic death-inducing 15-hydroperoxy-arachidonic acid phosphatidylethanolamine, triggering ferroptosis in epithelial cells
This medicine helps support muscle function, improve energy metabolism, and reduce fatigue associated with low carnitine levels
Ozone therapy is an emerging powerhouse for lowering thyroid antibodies and enhancing mitochondrial health
Clogging up your coronary arteries with cholesterol is a leading cause of congestive heart failure (ischemic heart disease), but there are other causes (COPD, emphysema etc.)
